Charity-funded clinical trial on cannabis and brain cancer gets underway
A cannabis charity raised over €400,000 to make the trial possible.
14 results for “glioblastoma”
A cannabis charity raised over €400,000 to make the trial possible.
The study aims to recruit more than 230 glioblastoma patients at 14 NHS hospitals across the UK.
We explore the findings from research into cancer and chronic pain to anxiety, PTSD and tooth loss.
Cannabis has been shown to benefit cancer patients in many different ways, but what does the science say?
The body wants to gain a “deeper understanding” of the effects cannabis has on cancer
To mark World Cancer Day, we examine the science to see if CBD or medical cannabis could help.
This is the first study on tumours that examines inhalation as an effective way of administering CBD
A Phase II trial of Sativex, in patients with the most severe form of brain tumour, will open in 2022.
The Olympian diver is supporting a cannabis-based drug trial for an aggressive form of brain cancer.
A phase I study showed promising results in extending survival for patients
An early UK trial suggests that cannabis-based drug Sativex, used alongside chemotherapy, could improve life-expectancy in patients with severe brain cancer. An oral spray containing cannabis-derived chemical extracts is well […]
MGC Pharmaceuticals has announced the expansion of its ongoing study into the effects of cannabinoids on Glioblastoma Multiforme (‘GBM’), the most aggressive and treatment-resistant form of brain cancer. The company […]
CBD oils are equally or less effective at inhibiting the growth of certain cancer cells compared to pure CBD, a US study suggests. Research indicates that future studies into the […]
Findings from a new study examining human and canine brain cancer cells suggest that CBD could be a useful therapy for a difficult-to-treat brain cancer.